1.
Jayanthi JL, Mallia RJ, Shiny ST, Baiju KV, Mathews A, Kumar R, et al.
Discriminant analysis of autofluorescence spectra for classification of
oral lesions in vivo. Lasers Surg Med. 2009;41:345-52.
http://dx.doi.org/10.1002/lsm.20771
|
|
2.
Mishra R. Biomarkers of oral premalignant epithelial lesions for clinical
application. Oral Oncol. 2012;48:578-84.
http://dx.doi.org/10.1016/j.oraloncology.2012.01.017
|
|
|
3.
Marocchio LS, Lima J, Sperandio FF, Corra L, de Sousa SO. Oral squamous
cell carcinoma: an analysis of 1,564 cases showing advances in early
detection. J Oral Sci. 2010;52:267-73.
http://dx.doi.org/10.2334/josnusd.52.267
|
|
|
4.
Rana M, Zapf A, Kuehle M, Gellrich NC, Eckardt AM. Clinical evaluation of
an autofluorescence diagnostic device for oral cancer detection: a
prospective randomized diagnostic study. Eur J Cancer Prev. 2012;21:460-6.
http://dx.doi.org/10.1097/CEJ.0b013e32834fdb6d
|
|
|
5.
Koch FP, Kunkel M, Biesterfeld S, Wagner W. Diagnostic efficiency of
differentiating small cancerous and precancerous lesions using mucosal
brush smears of the oral cavity: A prospective and blinded study. Clin Oral
Investig. 2011;15:763-9.
http://dx.doi.org/10.1007/s00784-010-0434-6
|
|
|
6.
Remmerbach TW, Meyer-Ebrecht D, Aach T, WŸrflinger T, Bell AA, Schneider
TE, et al. Toward a multimodal cell analysis of brush biopsies for the
early detection of oral cancer. Cancer. 2009;117:228-35.
http://dx.doi.org/10.1002/cncy.20028
|
|
|
7.
Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, et al.
Evidence-based clinical recommendations regarding screening for oral
squamous cell carcinomas. J Am Dent Assoc. 2010;141:509-20.
http://dx.doi.org/10.14219/jada.archive.2010.0223
|
|
|
8.
Messadi DV. Diagnostic aids for detection of oral precancerous conditions.
Int J Oral Sci. 2013;5:59-65.
http://dx.doi.org/10.1038/ijos.2013.24
|
|
|
9.
Sloan P. Squamous cell carcinoma and precursor lesions: clinical
presentation. Periodontol 2000. 2011;57:10-8.
http://dx.doi.org/10.1111/j.1600-0757.2011.00391.x
|
|
|
10.
Bhalang K, Suesuwan A, Dhanuthai K, Sannikorn P, Luangjarmekorn L,
Swasdison S. The application of acetic acid in the detection of oral
squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
2008;106:371-6.
http://dx.doi.org/10.1016/j.tripleo.2008.01.017
|
|
|
11.
Bhatia N, Lalla Y, Vu AN, Farah CS. Advances in optical adjunctive AIDS for
visualisation and detection of oral malignant and potentially malignant
lesions. Int J Dent. 2013;2013:194029.
http://dx.doi.org/10.1155/2013/194029
|
|
|
12.
Markopoulos AK. Current aspects on oral squamous cell carcinoma. Open Dent
J. 2012;6:126-30.
http://dx.doi.org/10.2174/1874210601206010126
|
|
|
13.
Chen YW, Lin JS, Wu CH, Lui MT, Kao SY, Fong Y. Application of in vivo
stain of methylene blue as a diagnostic aid in the early detection and
screening of oral squamous cell carcinoma and precancer lesions. J Chin Med
Assoc. 2007;70:497-503.
http://dx.doi.org/10.1016/S1726-4901(08)70048-0
|
|
|
14.
Saini R, Poh CF. Photodynamic therapy: a review and its prospective role in
the management of oral potentially malignant disorders. Oral Dis.
2013;19:440-51.
|
|
|
15.
Epstein JB, GŸneri P. The adjunctive role of toluidine blue in detection of
oral premalignant and malignant lesions. Curr Opin Otolaryngol Head Neck
Surg. 2009;17:79-87.
http://dx.doi.org/10.1097/MOO.0b013e32832771da
|
|
|
16.
Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and
classification of potentially malignant disorders of the oral mucosa. J
Oral Pathol Med. 2007;36:575-80.
http://dx.doi.org/10.1111/j.1600-0714.2007.00582.x
|
|
|
17.
Feller L, Lemmer J. Oral Leukoplakia as It Relates to HPV Infection: A
Review. Int J Dent. 2012;2012:540561.
http://dx.doi.org/10.1155/2012/540561
|
|
|
18.
Sciubba JJ. Oral Cancer: The importance of early diagnosis and treatment.
Am J Clin Dermatol. 2001;4:239-51.
http://dx.doi.org/10.2165/00128071-200102040-00005
|
|
|
19.
Dos santos Pereira J, De Vasconcelos Carvalho M, Gomes Henriques AC, De
Queiroz Camara TH, De Costa Miguel MC, De Almeida Freitas R. Epidemiology
and correlation of the clinicopathlogical features in oral epitelial
displasia: Analysis of 173 cases. Ann Diagn Pathol. 2011;15:98-102.
http://dx.doi.org/10.1016/j.anndiagpath.2010.08.008
|
|
|
20.
Hanken H, Kraatz J, Smeets R, Heiland M, Assaf AT, Blessmann M, et al. The
detection of oral pre- malignant lesions with an autofluorescence based
imaging system (VELscopeª) - a single blinded clinical evaluation. Head
Face Med. 2013;9:23.
http://dx.doi.org/10.1186/1746-160X-9-23
|
|
|
21.
Moro A, Di Nardo F, Boniello R, Marianetti TM, Cervelli D, Gaspardini G, et
al. Autofluorescence and early detection of mucosal lesions in patients at
risk for oral cancer. J Craniofac Surg. 2010;21:1899-903.
http://dx.doi.org/10.1097/SCS.0b013e3181f4afb4
|
|
|
22.Pentenero
M, Navone R, Motta F, Marino R, Gassino L, Broccoletti R, et al. Clinical
features of microinvasive stage I oral carcinoma. Oral Dis.
2011;17:298-303.
http://dx.doi.org/10.1111/j.1601-0825.2010.01740.x
|
|
|
23.
Mehrotra R, Yadav S. Oral squamous cell carcinoma: Etiology, pathogenesis
and prognostic value of genomic alterations. Indian J Cancer. 2006;43:60-6.
http://dx.doi.org/10.4103/0019-509X.25886
|
|
|
24.
Lingen MW, Pinto A, Mendes RA, Franchini R, Czerninski R, Tilakaratne WM,
et al. Genetics/epigenetics of oral premalignancy: current status and
future research. Oral Dis. 2011;17:7-22.
http://dx.doi.org/10.1111/j.1601-0825.2011.01789.x
|
|
|
25.
Bremmer JF, Graveland AP, Brink A, Braakhuis BJ, Kuik DJ, Leemans CR, et
al. Screening for oral precancer with noninvasive genetic cytology. Cancer
Prev Res (Phila). 2009;2:128-33.
http://dx.doi.org/10.1158/1940-6207.CAPR-08-0128
|
|
|
26.
Brocklehurst PR, Baker SR, Speight PM. A qualitative study examining the
experience of primary care dentists in the detection and management of
potentially malignant lesions. 1. Factors influencing detection and the
decision to refer. Br Dent J. 2010;208:72-3.
http://dx.doi.org/10.1038/sj.bdj.2010.99
|
|
|
27.
Garg P, Karjodkar F. "Catch Them before it Becomes Too Late"-Oral
Cancer Detection. Report of Two Cases and Review of Diagnostic AIDS in
Cancer Detection. Int J Prev Med. 2012;3:737-41.
|
|
|
28.
Epstein JB, Silverman S, Epstein JD, Lonky SA, Bride MA. Analysis of oral
lesion biopsies identified and evaluated by visual examination,
chemiluminescence and toluidine blue. Oral Oncol. 2008;44:538-44.
http://dx.doi.org/10.1016/j.oraloncology.2007.08.011
|
|
|
29.
Epstein JB, Guneri P, Boyacioglu H, Abt E. The limitations of the clinical
oral examination in detecting dysplastic oral lesions and oral squamous cell
carcinoma. J Am Dent Assoc. 2012;143:1332-42.
http://dx.doi.org/10.14219/jada.archive.2012.0096
|
|
|
30.
Bremmer JF, Braakhuis BJ, Ruijter-Schippers HJ, Brink A, Duarte HM, Kuik
DJ, et al. A noninvasive genetic screening test to detect oral
preneoplastic lesions. Lab Invest. 2005;85:1481-8.
http://dx.doi.org/10.1038/labinvest.3700342
|
|
|
31.
Delavarian Z, Mohtasham N, Mosannen-Mozafari P, Pakfetrat A, Shakeri MT,
Ghafoorian-Maddah R. Evaluation of the diagnostic value of a Modified
Liquid-Based Cytology using OralCDx Brush in early detection of oral
potentially malignant lesions and oral cancer. Med Oral Patol Oral Cir
Bucal. 2010;15:e671-6.
http://dx.doi.org/10.4317/medoral.15.e671
|
|
|
32.
Sankaranarayanan R, Wesley R, Thara S, Dhakad N, Chandralekha B, Sebastian
P, et al. Test characteristics of visual inspection with 4% acetic acid
(VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala,
India. Int J Cancer. 2003;106:404-8.
http://dx.doi.org/10.1002/ijc.11245
|
|
|
33.
Epstein JB, Scully C, Spinelli J. Toluidine blue and lugol's iodine
application in the assessment of oral malignant disease and lesions at risk
of malignancy. J Oral Pathol Med. 1992;21:160-3.
http://dx.doi.org/10.1111/j.1600-0714.1992.tb00094.x
|
|
|
34.
Rosenberg D, Cretin S. Use of meta-analysis to evaluate tolonium chloride
in oral cancer screening. Oral Surg Oral Med Oral Pathol. 1989;67:621-7.
http://dx.doi.org/10.1016/0030-4220(89)90286-7
|
|
|
35.
Peng G, Long Q, Wu Y, Zhao J, Chen L, Li X. Evaluation of double vital
staining with lugol's iodine and methylene blue in diagnosis superficial
esophageal lesions. Scand J Gastroenterol. 2011;46:406-13.
http://dx.doi.org/10.3109/00365521.2010.545829
|
|
|
36.
Du GF, Li CZ, Chen HZ, Chen XM, Xiao Q, Cao ZG, et al. Rose bengal staining
in detection of oral precancerous and malignant lesions with colorimetric
evaluation: a pilot study. Int J Cancer. 2007;120:1958-63.
http://dx.doi.org/10.1002/ijc.22467
|
|
|
37.
Watanabe A, Taniguchi M, Tsujie H, Hosokawa M, Fujita M, Sasaki S. Clinical
impact of iodine staining for diagnosis of carcinoma in situ in the floor
of mouth, and decision of adequate surgical margin. Auris Nasus Larynx.
2012;39:193-7.
http://dx.doi.org/10.1016/j.anl.2011.08.004
|
|
|
38.
Patton LL, Epstein JB, Kerr AR. Adjunctive techniques for oral cancer
examination and lesion diagnosis: a systematic review of the literatura. J
Am Dent Assoc. 2008;139:896-905.
http://dx.doi.org/10.14219/jada.archive.2008.0276
|
|
|
39.
Lingen MW, Kalmar JR, Karrison T, Speigh PM. Critical evaluation of
diagnostic aids for the detection of oral cancer. Oral Oncol.
2008;44:10-22.
http://dx.doi.org/10.1016/j.oraloncology.2007.06.011
|
|
|
40.
Koch FP, Kaemmerer PW, Biesterfeld S, Kunkel M, Wagner W. Effectiveness of
autofluorescence to identify suspicious oral lesions--a prospective,
blinded clinical trial. Clin Oral Investig. 2011;15:975-82.
http://dx.doi.org/10.1007/s00784-010-0455-1
|
|
|
41.
Lane PM, Gilhuly T, Whitehead P, Zeng H, Poh CF, Ng S, et al. Simple device
for the direct visualization of oral-cavity tissue fluorescence. J Biomed
Opt. 2006;11:024006.
http://dx.doi.org/10.1117/1.2193157
|
|
|
42.
McNamara K, Martin BD, Evans EW, Kalmar JR. The role of direct visual
fluorescent examination (VELscope) in routine screening for potentially
malignant oral mucosal lesions. Oral Surg Oral Med Oral Pathol Oral Radiol.
2012;114:636-43.
http://dx.doi.org/10.1016/j.oooo.2012.07.484
|
|
|
43.
Schwarz RA, Gao W, Redden Weber C, Kurachi C, Lee JJ, El-Naggar AK, et al.
Noninvasive evaluation of oral lesions using depth-sensitive optical
spectroscopy: Simple device for the direct visualization of oral-cavity
tissue fluorescence. Cancer. 2009;115:1669-79.
http://dx.doi.org/10.1002/cncr.24177
|
|
|
44.
McGee S, Mirkovic J, Mardirossian V, Elackattu A, Yu CC, Kabani S, et al.
Model-based spectroscopic analysis of the oral-cavity: Impact of anatomy. J
Biomed Opt. 2008;13:064034.
http://dx.doi.org/10.1117/1.2992139
|
|
|
45.
Roblyer D, Furachi C, Stepanek V, Williams MD, El-Naggar AK, Lee JJ, et al.
Objective detection and delineation of oral neoplasia using
autofluorescence imaging. Cancer Prev Res(Phila). 2009;2:423-31.
http://dx.doi.org/10.1158/1940-6207.CAPR-08-0229
|
|
|
46.
Nguyen P, Bashirzadeh F, Hodge R, Agnew J, Farah CS, Duhig E, et al. High
specificity of combined narrow band imaging and autofluorescence mucosal
assessment of patients with head and neck c‡ncer. Head Neck.
2013;35:619-25.
http://dx.doi.org/10.1002/hed.22999
|
|
|
47.
Mojsa I, Kaczmarzyk T, Zaleska M, Stypulkowska J, Zapala-Pospiech A,
Sadecki D. Value of the ViziLite Plus System as a diagnostic aid in the
early detection of oral cancer/premalignant epithelial lesions. J Craniofac
Surg. 2012;23:162-4.
http://dx.doi.org/10.1097/SCS.0b013e31824cdbea
|
|
|
48.
Goodson ML, Thomson PJ. Management of oral carcinoma: Benefits of early
precancerous intervention. Br J Oral Maxillofac Surg. 2011;49:88-91.
http://dx.doi.org/10.1016/j.bjoms.2009.12.014
|
|
|
49.
Cercadillo-Ibarguren I, Espa-a-Tost A, Arnabat-Dom’nguez J,
Valmaseda-Castell—n E, Berini-AytŽs L, Gay-Escoda C. Histologic evaluation
of thermal damage produced on soft tissues by CO2, Er,Cr:YSGG and diode
lasers. Med Oral Patol Oral Cir Bucal. 2010;15:e912-8.
http://dx.doi.org/10.4317/medoral.15.e912
|
|
|
50.
Fontes KB, Cunha KS, Rodriguez FR, Silva LE, DIas EP. Concordance between
cytopathology and incisional biopsy in the diagnosis of oral squamous cell
carcinoma. Braz Oral Res. 2013;27:122-7.
|
|
|
51.
KŠmmerer PW, Koch FP, Santoro M, Babaryka G, Biesterfeld S, Brieger J, et
al. Prospective, blinded comparison of cytology and DNA-image cytometry of
brush biopsies for early detection of oral malignancy. Oral Oncol.
2013;49:420-6.
http://dx.doi.org/10.1016/j.oraloncology.2012.12.006
|
|
|
52.
Mehrotra R, Gupta A, Singh M, Ibrahim R. Application of cytology and
molecular biology in diagnosing premalignant or malignant oral lesions. Mol
Cancer. 2006;5:11.
http://dx.doi.org/10.1186/1476-4598-5-11
|
|
|
53.
…gmundsd—ttir HM, Hilmarsd—ttir H, Bjšrnsson J, Holbrook WP. Longitudinal
study of TP53 mutations in eight patients with potentially malignant oral
mucosal disorders. J Oral Pathol Med. 2009;38:716-21.
http://dx.doi.org/10.1111/j.1600-0714.2009.00767.x
|
|
|
54.
Donadini A, Maffei M, Cavallero A, Pentenero M, Malacarne D, Di Nallo E, et
al. Oral cancer genesis and progression: DNA near-diploid aneuploidization
and endoreduplication by high resolution flow cytometry. Cell Oncol.
2010;32:373-83.
|
|
|
55.
Rosas SL, Koch W, da Costa Carvalho MG, Wu L, Califano J, Westra W, et al.
Promoter hypermethylation patterns of p16, O6-methylguanine-DNA
methyltransferase, and death-associated protein kinase in tumors and saliva
of head and neck cancer patients. Cancer Res. 2001;61:939-42.
|
|
|
56.
Huang MF, Chang YC, Liao PS, Huang TH, Tsay CH, Chou MY. Loss of
heterozygosity of p53 gene of oral cancer detected by exfoliative cytology.
Oral Oncol. 1999;35:296-301.
http://dx.doi.org/10.1016/S1368-8375(98)00119-5
|
|
|
57.
Nunes DN, Kowalski LP, Simpson AJ. Detection of oral and oropharyngeal
cancer by microsatellite analysis in mouth washes and lesion brushings.
Oral Oncol. 2000;36:525-8.
http://dx.doi.org/10.1016/S1368-8375(00)00045-2
|
|
|
58.
Partridge M, Pateromichelakis S, Phillips E, Emilion GG, A'Hern RP, Langdon
JD. A case-control study confirms that microsatellite assay can identify
patients at risk of developing oral squamous cell carcinoma within a field
cancerization. Cancer Res. 2000;60:3893-8.
|
|
|
59.
Remmerbach TW, Weidenbach H, Muller C, Hemprich A, Pomjanski N, Buckstegge
B, et al. Diagnostic value of nucleolar organizer regions (AgNORs) in brush
biopsies of suspicious lesions of the oral cavity. Anal Cell Pathol. 2003;25:139-46.
http://dx.doi.org/10.1155/2003/647685
|
|
|
60.
Nayak S, Goel MM, Chandra S, Bhatia V, Mehrotra D, Kumar S, et al. VEGF-A
immunohistochemical and mRNA expression in tissues and its serum levels in
potentially malignant oral lesions and oral squamous cell carcinomas. Oral
Oncol. 2012;48:233-9.
http://dx.doi.org/10.1016/j.oraloncology.2011.10.003
|
|
|
61.
Scott IS, Odell E, Chatrath P, Morris LS, Davies RJ, Vowler SL, et al. A
minimally invasive immunocytochemical approach to early detection of oral
squamous cell carcinoma and dysplasia. Br J Cancer. 2006;94:1170-5.
http://dx.doi.org/10.1038/sj.bjc.6603066
|
|
|
62.
Liao CT, Fan KH, Lin CY, Wang HM, Huang SF, Chen IH, et al. Impact of a
second FDG PET scan before adjuvant therapy for the early detection of
residual/relapsing tumours in high-risk patients with oral cavity cancer
and pathological extracapsular spread. Eur J Nucl Med Mol Imaging.
2012;39:944-55.
http://dx.doi.org/10.1007/s00259-012-2103-2
|
|
|
63.
Hamdoon Z, Jerjes W, Upile T, McKenzie G, Jay A, Hopper C. Optical
coherence tomography in the assessment of suspicious oral lesions: An
immediate ex vivo study. Photodiagnosis Photodyn Ther. 2013;10:17-27.
http://dx.doi.org/10.1016/j.pdpdt.2012.07.005
|
|
|
64.
Jerjes W, Upile T, Conn B, Hamdoon Z, Betz CS, McKenzie G, et al. In vitro
examination of suspicious oral lesions using optical coherence tomography.
Br J Oral Maxillofac Surg. 2010;48:18-25.
http://dx.doi.org/10.1016/j.bjoms.2009.04.019
|
|
|
65.
Ahn YC, Chung J, Wilder-Smith P, Chen Z. Multimodality approach to optical
early detection and mapping of oral neoplasia. J Biomed Opt.
2011;16:076007.
http://dx.doi.org/10.1117/1.3595850
|
|
|